Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Gabriele Donati; Chiara Abenavoli; Gisella Vischini; Giovanna Cenacchi; Roberta Costa; Gianandrea Pasquinelli; Manuela Ferracin; Noemi Laprovitera; Giorgia Comai; Giorgio Monti; Fabrizio Giostra; Gaetano La Manna

doi:10.12659/AJCR.934220

23 February 2022 : Case report Italy

Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Rare coexistence of disease or pathology

Gabriele Donati^1AE, Chiara Abenavoli^1BF, Gisella Vischini^1E, Giovanna Cenacchi^23C, Roberta Costa^23C, Gianandrea Pasquinelli^4C, Manuela Ferracin

^5C, Noemi Laprovitera

^5C, Giorgia Comai^1D, Giorgio Monti^6D, Fabrizio Giostra^6D, Gaetano La Manna^1A*

DOI: 10.12659/AJCR.934220

Am J Case Rep 2022; 23:e934220

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Immunohistochemistry on muscle biopsy for CD68 shows endomysial infiltrate especially characterized by CD68 macrophages (black stars).

Back to the Article

Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Your Privacy